Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Research Report 2026(Status and Outlook)
Live Biotherapeutic Products (LBPs) are biotherapeutic products based on live microorganisms that are intended to treat or prevent disease by modulating the microbiome. These products are usually prepared from specific strains of microorganisms that have potential therapeutic effects, such as improving gut health, boosting the immune system, or reducing inflammation.The rising importance of the potential advantages of live biotherapeutic products and microbiome-based therapeutics in treating a variety of diseases, including inflammatory bowel disease, cancer, and neurological disorders, among patients and healthcare providers is the prime factor that propels market growth.CDMOs specializing in these fields have the expertise and infrastructure to support developing and manufacturing these complex therapies, which require specialized equipment and facilities. As a result, pharmaceutical and biotech companies can outsource their production to CDMOs, allowing them to focus on research and development.
The global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market size was estimated at USD 189.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market.
Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lallemand Health Solutions
Wacker Chemie AG
Biose Industrie
List Biological Labs, Inc.
NIZO
SGS (Quay Pharmaceuticals)
Assembly Biosciences, Inc.
Recipharm (Arranta Bio)
Bacthera (Novonesis+Lonza)
Smaltis
Lonza
vermicon AG
Market Segmentation (by Type)
Solid Dosage Form
Liquid Dosage Form
Market Segmentation (by Application)
Digestive System Diseases
Immune System Diseases
Metabolic Diseases
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market
Overview of the regional outlook of the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market size was estimated at USD 189.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service market.
Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lallemand Health Solutions
Wacker Chemie AG
Biose Industrie
List Biological Labs, Inc.
NIZO
SGS (Quay Pharmaceuticals)
Assembly Biosciences, Inc.
Recipharm (Arranta Bio)
Bacthera (Novonesis+Lonza)
Smaltis
Lonza
vermicon AG
Market Segmentation (by Type)
Solid Dosage Form
Liquid Dosage Form
Market Segmentation (by Application)
Digestive System Diseases
Immune System Diseases
Metabolic Diseases
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market
Overview of the regional outlook of the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service
1.2 Key Market Segments
1.2.1 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Segment by Type
1.2.2 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Life Cycle
3.3 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue Market Share by Company (2020-2025)
3.4 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Competitive Situation and Trends
3.6.1 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE VALUE CHAIN ANALYSIS
4.1 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Porter's Five Forces Analysis
6 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market by Type (2020-2025)
6.3 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Type (2021-2025)
7 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) by Application (2020-2025)
7.3 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Application (2021-2025)
8 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.1.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.1.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region
8.2 North America
8.2.1 North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lallemand Health Solutions
9.1.1 Lallemand Health Solutions Basic Information
9.1.2 Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.1.3 Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.1.4 Lallemand Health Solutions SWOT Analysis
9.1.5 Lallemand Health Solutions Business Overview
9.1.6 Lallemand Health Solutions Recent Developments
9.2 Wacker Chemie AG
9.2.1 Wacker Chemie AG Basic Information
9.2.2 Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.2.3 Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.2.4 Wacker Chemie AG SWOT Analysis
9.2.5 Wacker Chemie AG Business Overview
9.2.6 Wacker Chemie AG Recent Developments
9.3 Biose Industrie
9.3.1 Biose Industrie Basic Information
9.3.2 Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.3.3 Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.3.4 Biose Industrie SWOT Analysis
9.3.5 Biose Industrie Business Overview
9.3.6 Biose Industrie Recent Developments
9.4 List Biological Labs, Inc.
9.4.1 List Biological Labs, Inc. Basic Information
9.4.2 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.4.3 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.4.4 List Biological Labs, Inc. Business Overview
9.4.5 List Biological Labs, Inc. Recent Developments
9.5 NIZO
9.5.1 NIZO Basic Information
9.5.2 NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.5.3 NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.5.4 NIZO Business Overview
9.5.5 NIZO Recent Developments
9.6 SGS (Quay Pharmaceuticals)
9.6.1 SGS (Quay Pharmaceuticals) Basic Information
9.6.2 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.6.3 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.6.4 SGS (Quay Pharmaceuticals) Business Overview
9.6.5 SGS (Quay Pharmaceuticals) Recent Developments
9.7 Assembly Biosciences, Inc.
9.7.1 Assembly Biosciences, Inc. Basic Information
9.7.2 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.7.3 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.7.4 Assembly Biosciences, Inc. Business Overview
9.7.5 Assembly Biosciences, Inc. Recent Developments
9.8 Recipharm (Arranta Bio)
9.8.1 Recipharm (Arranta Bio) Basic Information
9.8.2 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.8.3 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.8.4 Recipharm (Arranta Bio) Business Overview
9.8.5 Recipharm (Arranta Bio) Recent Developments
9.9 Bacthera (Novonesis+Lonza)
9.9.1 Bacthera (Novonesis+Lonza) Basic Information
9.9.2 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.9.3 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.9.4 Bacthera (Novonesis+Lonza) Business Overview
9.9.5 Bacthera (Novonesis+Lonza) Recent Developments
9.10 Smaltis
9.10.1 Smaltis Basic Information
9.10.2 Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.10.3 Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.10.4 Smaltis Business Overview
9.10.5 Smaltis Recent Developments
9.11 Lonza
9.11.1 Lonza Basic Information
9.11.2 Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.11.3 Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.11.4 Lonza Business Overview
9.11.5 Lonza Recent Developments
9.12 vermicon AG
9.12.1 vermicon AG Basic Information
9.12.2 vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.12.3 vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.12.4 vermicon AG Business Overview
9.12.5 vermicon AG Recent Developments
10 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET FORECAST BY REGION
10.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast
10.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country
10.2.3 Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Region
10.2.4 South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Forecast by Type (2026-2035)
11.1.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Type (2026-2035)
11.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Forecast by Application (2026-2035)
11.2.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service
1.2 Key Market Segments
1.2.1 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Segment by Type
1.2.2 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Life Cycle
3.3 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue Market Share by Company (2020-2025)
3.4 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Competitive Situation and Trends
3.6.1 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE VALUE CHAIN ANALYSIS
4.1 Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Porter's Five Forces Analysis
6 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market by Type (2020-2025)
6.3 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Type (2021-2025)
7 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) by Application (2020-2025)
7.3 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Application (2021-2025)
8 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.1.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.1.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region
8.2 North America
8.2.1 North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lallemand Health Solutions
9.1.1 Lallemand Health Solutions Basic Information
9.1.2 Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.1.3 Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.1.4 Lallemand Health Solutions SWOT Analysis
9.1.5 Lallemand Health Solutions Business Overview
9.1.6 Lallemand Health Solutions Recent Developments
9.2 Wacker Chemie AG
9.2.1 Wacker Chemie AG Basic Information
9.2.2 Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.2.3 Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.2.4 Wacker Chemie AG SWOT Analysis
9.2.5 Wacker Chemie AG Business Overview
9.2.6 Wacker Chemie AG Recent Developments
9.3 Biose Industrie
9.3.1 Biose Industrie Basic Information
9.3.2 Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.3.3 Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.3.4 Biose Industrie SWOT Analysis
9.3.5 Biose Industrie Business Overview
9.3.6 Biose Industrie Recent Developments
9.4 List Biological Labs, Inc.
9.4.1 List Biological Labs, Inc. Basic Information
9.4.2 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.4.3 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.4.4 List Biological Labs, Inc. Business Overview
9.4.5 List Biological Labs, Inc. Recent Developments
9.5 NIZO
9.5.1 NIZO Basic Information
9.5.2 NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.5.3 NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.5.4 NIZO Business Overview
9.5.5 NIZO Recent Developments
9.6 SGS (Quay Pharmaceuticals)
9.6.1 SGS (Quay Pharmaceuticals) Basic Information
9.6.2 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.6.3 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.6.4 SGS (Quay Pharmaceuticals) Business Overview
9.6.5 SGS (Quay Pharmaceuticals) Recent Developments
9.7 Assembly Biosciences, Inc.
9.7.1 Assembly Biosciences, Inc. Basic Information
9.7.2 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.7.3 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.7.4 Assembly Biosciences, Inc. Business Overview
9.7.5 Assembly Biosciences, Inc. Recent Developments
9.8 Recipharm (Arranta Bio)
9.8.1 Recipharm (Arranta Bio) Basic Information
9.8.2 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.8.3 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.8.4 Recipharm (Arranta Bio) Business Overview
9.8.5 Recipharm (Arranta Bio) Recent Developments
9.9 Bacthera (Novonesis+Lonza)
9.9.1 Bacthera (Novonesis+Lonza) Basic Information
9.9.2 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.9.3 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.9.4 Bacthera (Novonesis+Lonza) Business Overview
9.9.5 Bacthera (Novonesis+Lonza) Recent Developments
9.10 Smaltis
9.10.1 Smaltis Basic Information
9.10.2 Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.10.3 Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.10.4 Smaltis Business Overview
9.10.5 Smaltis Recent Developments
9.11 Lonza
9.11.1 Lonza Basic Information
9.11.2 Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.11.3 Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.11.4 Lonza Business Overview
9.11.5 Lonza Recent Developments
9.12 vermicon AG
9.12.1 vermicon AG Basic Information
9.12.2 vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
9.12.3 vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Market Performance
9.12.4 vermicon AG Business Overview
9.12.5 vermicon AG Recent Developments
10 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) AND MICROBIOME CDMO SERVICE MARKET FORECAST BY REGION
10.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast
10.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country
10.2.3 Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Region
10.2.4 South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Forecast by Type (2026-2035)
11.1.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Type (2026-2035)
11.2 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Forecast by Application (2026-2035)
11.2.1 Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Type (M USD)
Table 4. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Application
Table 5. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Comparison by Region (M USD)
Table 6. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) by Company (2020-2025)
Table 7. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products (LBP) and Microbiome CDMO Service as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Type (M USD)
Table 22. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) by Type (2020-2025)
Table 23. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Type (2020-2025)
Table 24. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Type (2021-2025)
Table 25. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Application
Table 26. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Application (2020-2025) & (M USD)
Table 27. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application (2020-2025)
Table 28. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Application (2021-2025)
Table 29. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region (2020-2025) & (M USD)
Table 30. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region (2020-2025)
Table 31. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region (2020-2025) & (M USD)
Table 34. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region (2020-2025) & (M USD)
Table 36. Lallemand Health Solutions Basic Information
Table 37. Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 38. Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Lallemand Health Solutions SWOT Analysis
Table 40. Lallemand Health Solutions Business Overview
Table 41. Lallemand Health Solutions Recent Developments
Table 42. Wacker Chemie AG Basic Information
Table 43. Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 44. Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Wacker Chemie AG SWOT Analysis
Table 46. Wacker Chemie AG Business Overview
Table 47. Wacker Chemie AG Recent Developments
Table 48. Biose Industrie Basic Information
Table 49. Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 50. Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Biose Industrie SWOT Analysis
Table 52. Biose Industrie Business Overview
Table 53. Biose Industrie Recent Developments
Table 54. List Biological Labs, Inc. Basic Information
Table 55. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 56. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. List Biological Labs, Inc. Business Overview
Table 58. List Biological Labs, Inc. Recent Developments
Table 59. NIZO Basic Information
Table 60. NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 61. NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 62. NIZO Business Overview
Table 63. NIZO Recent Developments
Table 64. SGS (Quay Pharmaceuticals) Basic Information
Table 65. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 66. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 67. SGS (Quay Pharmaceuticals) Business Overview
Table 68. SGS (Quay Pharmaceuticals) Recent Developments
Table 69. Assembly Biosciences, Inc. Basic Information
Table 70. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 71. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Assembly Biosciences, Inc. Business Overview
Table 73. Assembly Biosciences, Inc. Recent Developments
Table 74. Recipharm (Arranta Bio) Basic Information
Table 75. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 76. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Recipharm (Arranta Bio) Business Overview
Table 78. Recipharm (Arranta Bio) Recent Developments
Table 79. Bacthera (Novonesis+Lonza) Basic Information
Table 80. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 81. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Bacthera (Novonesis+Lonza) Business Overview
Table 83. Bacthera (Novonesis+Lonza) Recent Developments
Table 84. Smaltis Basic Information
Table 85. Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 86. Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Smaltis Business Overview
Table 88. Smaltis Recent Developments
Table 89. Lonza Basic Information
Table 90. Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 91. Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Lonza Business Overview
Table 93. Lonza Recent Developments
Table 94. vermicon AG Basic Information
Table 95. vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 96. vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 97. vermicon AG Business Overview
Table 98. vermicon AG Recent Developments
Table 99. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 100. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Type (2026-2035) & (M USD)
Table 106. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Type (M USD)
Table 4. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Application
Table 5. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Comparison by Region (M USD)
Table 6. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) by Company (2020-2025)
Table 7. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products (LBP) and Microbiome CDMO Service as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Type (M USD)
Table 22. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) by Type (2020-2025)
Table 23. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Type (2020-2025)
Table 24. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Type (2021-2025)
Table 25. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Application
Table 26. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Application (2020-2025) & (M USD)
Table 27. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application (2020-2025)
Table 28. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Application (2021-2025)
Table 29. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region (2020-2025) & (M USD)
Table 30. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region (2020-2025)
Table 31. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region (2020-2025) & (M USD)
Table 34. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Region (2020-2025) & (M USD)
Table 36. Lallemand Health Solutions Basic Information
Table 37. Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 38. Lallemand Health Solutions Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Lallemand Health Solutions SWOT Analysis
Table 40. Lallemand Health Solutions Business Overview
Table 41. Lallemand Health Solutions Recent Developments
Table 42. Wacker Chemie AG Basic Information
Table 43. Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 44. Wacker Chemie AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Wacker Chemie AG SWOT Analysis
Table 46. Wacker Chemie AG Business Overview
Table 47. Wacker Chemie AG Recent Developments
Table 48. Biose Industrie Basic Information
Table 49. Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 50. Biose Industrie Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Biose Industrie SWOT Analysis
Table 52. Biose Industrie Business Overview
Table 53. Biose Industrie Recent Developments
Table 54. List Biological Labs, Inc. Basic Information
Table 55. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 56. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. List Biological Labs, Inc. Business Overview
Table 58. List Biological Labs, Inc. Recent Developments
Table 59. NIZO Basic Information
Table 60. NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 61. NIZO Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 62. NIZO Business Overview
Table 63. NIZO Recent Developments
Table 64. SGS (Quay Pharmaceuticals) Basic Information
Table 65. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 66. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 67. SGS (Quay Pharmaceuticals) Business Overview
Table 68. SGS (Quay Pharmaceuticals) Recent Developments
Table 69. Assembly Biosciences, Inc. Basic Information
Table 70. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 71. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Assembly Biosciences, Inc. Business Overview
Table 73. Assembly Biosciences, Inc. Recent Developments
Table 74. Recipharm (Arranta Bio) Basic Information
Table 75. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 76. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Recipharm (Arranta Bio) Business Overview
Table 78. Recipharm (Arranta Bio) Recent Developments
Table 79. Bacthera (Novonesis+Lonza) Basic Information
Table 80. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 81. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Bacthera (Novonesis+Lonza) Business Overview
Table 83. Bacthera (Novonesis+Lonza) Recent Developments
Table 84. Smaltis Basic Information
Table 85. Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 86. Smaltis Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Smaltis Business Overview
Table 88. Smaltis Recent Developments
Table 89. Lonza Basic Information
Table 90. Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 91. Lonza Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Lonza Business Overview
Table 93. Lonza Recent Developments
Table 94. vermicon AG Basic Information
Table 95. vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Overview
Table 96. vermicon AG Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue (M USD) and Gross Margin (2020-2025)
Table 97. vermicon AG Business Overview
Table 98. vermicon AG Recent Developments
Table 99. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 100. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Type (2026-2035) & (M USD)
Table 106. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD), 2025-2035
Figure 5. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Life Cycle
Figure 12. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue Share by Company in 2025
Figure 13. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue in 2025
Figure 15. Value Chain Map of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service
Figure 16. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market PEST Analysis
Figure 17. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Type
Figure 20. Market Share of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service by Type (2020-2025)
Figure 21. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application
Figure 24. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application (2020-2025)
Figure 25. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application in 2024
Figure 26. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region (2020-2025)
Figure 28. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Country in 2024
Figure 30. U.S. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Country in 2024
Figure 35. Germany Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region in 2024
Figure 42. China Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (M USD)
Figure 48. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Country in 2024
Figure 49. Brazil Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share Forecast by Type (2026-2035)
Figure 61. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD), 2025-2035
Figure 5. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Product Life Cycle
Figure 12. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue Share by Company in 2025
Figure 13. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Revenue in 2025
Figure 15. Value Chain Map of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service
Figure 16. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market PEST Analysis
Figure 17. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Type
Figure 20. Market Share of Live Biotherapeutic Products (LBP) and Microbiome CDMO Service by Type (2020-2025)
Figure 21. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application
Figure 24. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application (2020-2025)
Figure 25. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Application in 2024
Figure 26. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region (2020-2025)
Figure 28. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Country in 2024
Figure 30. U.S. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share by Country in 2024
Figure 35. Germany Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region in 2024
Figure 42. China Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (M USD)
Figure 48. South America Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Country in 2024
Figure 49. Brazil Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share Forecast by Type (2026-2035)
Figure 61. Global Live Biotherapeutic Products (LBP) and Microbiome CDMO Service Market Share Forecast by Application (2026-2035)
